Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors.

@article{Mabuchi2009PostoperativeCN,
  title={Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors.},
  author={Seiji Mabuchi and Ken-ichirou Morishige and Fumiaki Isohashi and Yasuo Yoshioka and Takashi Takeda and Toshiya Yamamoto and Kiyoshi Yoshino and Takayuki Enomoto and Takehiro Inoue and Tadashi Kimura},
  journal={Gynecologic oncology},
  year={2009},
  volume={115 3},
  pages={482-7}
}
OBJECTIVES The aim of this study was to evaluate the efficacy of postoperative nedaplatin-based concurrent chemoradiotherapy (CCRT) in patients with FIGO stage IA2-IIB cervical cancer with adverse risk factors. METHODS We retrospectively reviewed the medical records of 183 patients with early-stage cervical cancer who had undergone radical surgery between April 1997 and March 2006. Of these, 68 patients displayed high-risk prognostic factors such as positive pelvic lymph nodes, parametrial… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 33 references

Phase I study of weekly nedaplatin and concurrent pelvic radiotherapy as adjuvant therapy after radical surgery for cervical cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society • 2008
View 3 Excerpts

Similar Papers

Loading similar papers…